免疫疗法癌症患者内分泌代谢评估清单：意大利肿瘤内科学协会 (AIOM)、意大利糖尿病内科医师协会 (AMD)、意大利糖尿病学会 (SID)、意大利内分泌学会 (SIE) 和意大利药理学会 (SIF) 多学科小组提出的建议

IF 9.6 1区医学 Q1 ONCOLOGY

Cancer treatment reviews Pub Date : 2024-04-03 DOI:10.1016/j.ctrv.2024.102734

Maria Chiara Zatelli , Antongiulio Faggiano MD , Antonella Argentiero , Romano Danesi , Stella D'Oronzo , Stefano Fogli , Tindara Franchina , Francesco Giorgino , Nicola Marrano , Dario Giuffrida , Stefania Gori , Giampiero Marino , Rossella Mazzilli , Matteo Monami , Monica Montagnani , Lelio Morviducci , Annalisa Natalicchio , Alberto Ragni , Valerio Renzelli , Antonio Russo , Marco Gallo

{"title":"免疫疗法癌症患者内分泌代谢评估清单：意大利肿瘤内科学协会 (AIOM)、意大利糖尿病内科医师协会 (AMD)、意大利糖尿病学会 (SID)、意大利内分泌学会 (SIE) 和意大利药理学会 (SIF) 多学科小组提出的建议","authors":"Maria Chiara Zatelli , Antongiulio Faggiano MD , Antonella Argentiero , Romano Danesi , Stella D'Oronzo , Stefano Fogli , Tindara Franchina , Francesco Giorgino , Nicola Marrano , Dario Giuffrida , Stefania Gori , Giampiero Marino , Rossella Mazzilli , Matteo Monami , Monica Montagnani , Lelio Morviducci , Annalisa Natalicchio , Alberto Ragni , Valerio Renzelli , Antonio Russo , Marco Gallo","doi":"10.1016/j.ctrv.2024.102734","DOIUrl":null,"url":null,"abstract":"<div><p>Immunotherapy with immune checkpoint inhibitors (ICI) is increasingly employed in oncology. National and international endocrine and oncologic scientific societies have provided guidelines for the management of endocrine immune-related adverse events. However, guidelines recommendations differ according to the specific filed, particularly pertaining to recommendations for the timing of endocrine testing. In this position paper, a panel of experts of the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), and Italian Society of Pharmacology (SIF) offers a critical multidisciplinary consensus for a clear, simple, useful, and easily applicable endocrine-metabolic assessment checklist for cancer patients on immunotherapy<strong><em>.</em></strong></p></div>","PeriodicalId":9537,"journal":{"name":"Cancer treatment reviews","volume":"126 ","pages":"Article 102734"},"PeriodicalIF":9.6000,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0305737224000616/pdfft?md5=cfc7522f3d26d0dbdd973f3f3f67c817&pid=1-s2.0-S0305737224000616-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group\",\"authors\":\"Maria Chiara Zatelli , Antongiulio Faggiano MD , Antonella Argentiero , Romano Danesi , Stella D'Oronzo , Stefano Fogli , Tindara Franchina , Francesco Giorgino , Nicola Marrano , Dario Giuffrida , Stefania Gori , Giampiero Marino , Rossella Mazzilli , Matteo Monami , Monica Montagnani , Lelio Morviducci , Annalisa Natalicchio , Alberto Ragni , Valerio Renzelli , Antonio Russo , Marco Gallo\",\"doi\":\"10.1016/j.ctrv.2024.102734\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Immunotherapy with immune checkpoint inhibitors (ICI) is increasingly employed in oncology. National and international endocrine and oncologic scientific societies have provided guidelines for the management of endocrine immune-related adverse events. However, guidelines recommendations differ according to the specific filed, particularly pertaining to recommendations for the timing of endocrine testing. In this position paper, a panel of experts of the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), and Italian Society of Pharmacology (SIF) offers a critical multidisciplinary consensus for a clear, simple, useful, and easily applicable endocrine-metabolic assessment checklist for cancer patients on immunotherapy<strong><em>.</em></strong></p></div>\",\"PeriodicalId\":9537,\"journal\":{\"name\":\"Cancer treatment reviews\",\"volume\":\"126 \",\"pages\":\"Article 102734\"},\"PeriodicalIF\":9.6000,\"publicationDate\":\"2024-04-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0305737224000616/pdfft?md5=cfc7522f3d26d0dbdd973f3f3f67c817&pid=1-s2.0-S0305737224000616-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer treatment reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0305737224000616\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0305737224000616","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

免疫检查点抑制剂（ICI）免疫疗法在肿瘤学中的应用越来越广泛。国家和国际内分泌和肿瘤科学协会已为内分泌免疫相关不良事件的管理提供了指南。然而，不同的指南建议根据具体的申报情况而有所不同，尤其是关于内分泌检测时机的建议。在这份立场文件中，由意大利肿瘤内科学会（AIOM）、意大利糖尿病内科医师协会（AMD）、意大利糖尿病学会（SID）、意大利内分泌学会（SIE）和意大利药理学会（SIF）的专家组成的专家小组达成了一项重要的多学科共识，即为接受免疫疗法的癌症患者制定一份清晰、简单、实用且易于应用的内分泌代谢评估清单。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group

Immunotherapy with immune checkpoint inhibitors (ICI) is increasingly employed in oncology. National and international endocrine and oncologic scientific societies have provided guidelines for the management of endocrine immune-related adverse events. However, guidelines recommendations differ according to the specific filed, particularly pertaining to recommendations for the timing of endocrine testing. In this position paper, a panel of experts of the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), and Italian Society of Pharmacology (SIF) offers a critical multidisciplinary consensus for a clear, simple, useful, and easily applicable endocrine-metabolic assessment checklist for cancer patients on immunotherapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer treatment reviews 医学-肿瘤学

CiteScore

21.40

自引率

0.80%

发文量

109

审稿时长

13 days

期刊介绍： Cancer Treatment Reviews Journal Overview: International journal focused on developments in cancer treatment research Publishes state-of-the-art, authoritative reviews to keep clinicians and researchers informed Regular Sections in Each Issue: Comments on Controversy Tumor Reviews Anti-tumor Treatments New Drugs Complications of Treatment General and Supportive Care Laboratory/Clinic Interface Submission and Editorial System: Online submission and editorial system for Cancer Treatment Reviews